Gene · 7399
Papers2,630
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,630
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An exosome-based specific transcriptomic signature for profiling regulation patterns and modifying tumor immune microenvironment infiltration in triple-negative breast cancer. | Front Immunol | 2023 | 38124743 | PubTator, text mining | PubMed |
| Editorial: Organ mimicking technologies and their applications in drug discovery. | Front Bioeng Biotechnol | 2023 | 38107621 | PubTator, text mining | PubMed |
| Leveraging a KRAS-based signature to predict the prognosis and drug sensitivity of colon cancer and identifying SPINK4 as a new biomarker. | Sci Rep | 2023 | 38097680 | PubTator, text mining | PubMed |
| Development and validation of an immune-related gene prognostic index for lung adenocarcinoma. | J Thorac Dis | 2023 | 38090291 | PubTator, text mining | PubMed |
| Multimodal photoacoustic microscopy, optical coherence tomography, and fluorescence imaging of USH2A knockout rabbits. | Sci Rep | 2023 | 38086867 | PubTator, text mining | PubMed |
| Progression of retinitis pigmentosa on static perimetry, optical coherence tomography, and fundus autofluorescence. | Sci Rep | 2023 | 38086860 | PubTator, text mining | PubMed |
| A New Variant in the PRPF6 Gene Leading to Retinitis Pigmentosa: A Case Report. | Cureus | 2023 | 38074011 | PubTator, text mining | PubMed |
| An Optical Coherence Tomography-Based Measure as an Independent Estimate of Retinal Function in Retinitis Pigmentosa. | Diagnostics (Basel) | 2023 | 38066762 | PubTator, text mining | PubMed |
| [Advances on gene therapy for USH2A exon 13 related inherited retinal dystrophy]. | Zhonghua Yan Ke Za Zhi | 2023 | 38061908 | PubTator, text mining | PubMed |
| An anoikis-related lncRNA signature is a useful tool for predicting the prognosis of patients with lung adenocarcinoma. | Heliyon | 2023 | 38053861 | PubTator, text mining | PubMed |
| An integrative evaluation of circadian gene TIMELESS as a pan-cancer immunological and predictive biomarker. | Eur J Med Res | 2023 | 38053143 | PubTator, text mining | PubMed |
| VirusHound-I: prediction of viral proteins involved in the evasion of host adaptive immune response using the random forest algorithm and generative adversarial network for data augmentation. | Brief Bioinform | 2023 | 38033292 | PubTator, text mining | PubMed |
| Fusing WGCNA and Machine Learning for Immune-Related Gene Prognostic Index in Lung Adenocarcinoma: Precision Prognosis, Tumor Microenvironment Profiling, and Biomarker Discovery. | J Inflamm Res | 2023 | 38026246 | PubTator, text mining | PubMed |
| Application of patient-derived induced pluripotent stem cells and organoids in inherited retinal diseases. | Stem Cell Res Ther | 2023 | 38012786 | PubTator, text mining | PubMed |
| A Molecular Genetic Analysis of RPE65-Associated Forms of Inherited Retinal Degenerations in the Russian Federation. | Genes (Basel) | 2023 | 38002999 | PubTator, text mining | PubMed |
| Intra-promoter switch of transcription initiation sites in proliferation signaling-dependent RNA metabolism. | Nat Struct Mol Biol | 2023 | 37996663 | PubTator, text mining | PubMed |
| Allelic hierarchy for USH2A influences auditory and visual phenotypes in South Korean patients. | Sci Rep | 2023 | 37981655 | PubTator, text mining | PubMed |
| Whole-Exome Sequencing of 21 Families: Candidate Genes for Early-Onset High Myopia. | Int J Mol Sci | 2023 | 37958660 | PubTator, text mining | PubMed |
| Leveraging a disulfidptosis/ferroptosis-based signature to predict the prognosis of lung adenocarcinoma. | Cancer Cell Int | 2023 | 37946181 | PubTator, text mining | PubMed |
| Construction and validation of a novel angiogenesis pattern to predict prognosis and immunotherapy efficacy in colorectal cancer. | Aging (Albany NY) | 2023 | 37938164 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7399/papers?page=13